Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Coralie Reger de Moura"'
Autor:
Baptiste Louveau, Coralie Reger de Moura, Maxime Battistella, Céleste Lebbé, Aurélie Sadoux, Pascal Merlet, Julie Delyon, Barouyr Baroudjian, Fanélie Jouenne, Samia Mourah, Laetitia Vercellino, Lauriane Goldwirt, Fanny Bouquet, Kevin Serror
Publikováno v:
Translational Oncology
Translational Oncology, Vol 13, Iss 2, Pp 275-286 (2020)
Translational Oncology, Vol 13, Iss 2, Pp 275-286 (2020)
The development of BRAF and MEK inhibitors (BRAFi/MEKi) has led to major advances in melanoma treatment. However, the emergence of resistance mechanisms limits the benefit duration and a complete response occurs in less than 20% of patients receiving
Autor:
Coralie Reger de Moura, Laetitia Da Meda, Adèle de Masson, F. Herms, Samia Mourah, Nicolas Dumaz, Céleste Lebbé, Maxime Battistella, Baptiste Louveau, Julie Delyon, Fanélie Jouenne, Aurélie Sadoux, Barouyr Baroudjian
Publikováno v:
Cancers
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1203 (2019)
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1203 (2019)
In BRAFV600mut metastatic melanoma, the combination of BRAF and MEK inhibitors (BRAFi, MEKi) has undergone multiple resistance mechanisms, limiting its clinical benefit and resulting in the need for response predicting biomarkers. Based on phase III